Monday, January 8, 2007

Calypso Medical Gets $42.2M

Seattle-based Calypso Medical Technologies said late last night that it has raised $42.2M in a Series D funding round. Calpyso saie that Apothecary Capital, Glenview Capital Management, and Pequot Capital have joined its existing investors in the round. Calpyso is developing medical devices used in radiation treatment for prostate cancer. More information »